A new global analysis released by the World Economic Forum has brought renewed attention to a long-standing imbalance in healthcare funding. Despite women representing nearly half of the world’s population, women’s health receives less than 10 percent of private healthcare investment. The report exposes how systemic underfunding continues to affect research, innovation, and access to care for conditions that disproportionately impact women.
Where Healthcare Investment Falls Short
According to the report, a large share of funding directed toward women’s health focuses on areas such as cancer, reproductive health, and maternal care. While these areas remain critically important, they do not represent the full spectrum of health challenges women face throughout their lives.
High-burden conditions such as cardiovascular disease, osteoporosis, menopause-related disorders, and Alzheimer’s disease remain significantly underfunded, even though they account for a substantial share of illness and mortality among women globally. For example, heart disease is the leading cause of death for women in many countries, yet research and diagnostic tools often remain male-centric.
The funding gap becomes even more pronounced for chronic and quality-of-life conditions. Disorders like endometriosis, polycystic ovary syndrome (PCOS), and menstrual health issues receive less than 2 percent of total healthcare investment, despite affecting millions of women and often causing long-term pain, infertility, mental health challenges, and reduced work productivity.
Consequences of Underinvestment
The lack of funding has far-reaching consequences. Many women experience delayed diagnoses, limited treatment options, and inadequate clinical guidelines. In some cases, symptoms are dismissed or misunderstood due to insufficient research and data specific to women’s biology.
This gap also slows medical innovation. Without targeted investment, the development of new diagnostics, personalized treatments, and preventive solutions remains limited. As a result, healthcare systems continue to rely on outdated approaches that fail to address women’s unique health needs across different life stages.
The Case for Greater Investment
Health advocates and economists argue that increasing investment in women’s health is not only a moral imperative but also an economic opportunity. Expanding research and transparency could lead to better health outcomes, reduced healthcare costs, and higher workforce participation.
Studies suggest that closing gaps in women’s healthcare could unlock billions of dollars in global economic value by improving productivity, reducing chronic illness, and lowering long-term care expenses. Better data and funding would also help reduce health disparities across income levels and regions.
A Path Forward
The report calls for stronger collaboration between governments, private investors, healthcare providers, and research institutions. Priorities include expanding clinical trials focused on women, improving health data collection, and supporting startups and innovations dedicated to women’s health solutions.
Conclusion
The World Economic Forum’s findings make one thing clear: women’s health remains one of the most underfunded areas in modern healthcare. Addressing this imbalance could accelerate breakthroughs in prevention, diagnosis, and treatment while improving quality of life for billions of women worldwide. As awareness grows, sustained investment will be essential to building a more equitable and effective global health system.